This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEB9606Q_M.jpg
Becton Dickinson announced earnings per share of $2.55 on revenue of $4.25B. Analysts polled by Investing.com anticipated EPS of $2.4 on revenue of $4.18B. That with comparison to EPS of $2.59 on revenue of $4.2B in the same period a year before. Becton Dickinson had reported EPS of $2.65 on revenue of $4.23B in the previous quarter. Analysts are expecting EPS of $2.81 and revenue of $4.22B in the upcoming quarter.
Becton Dickinson shares are down 4% from the beginning of the year , still down 9.62% from its 52 week high of $286.72 set on February 5. They are outperforming the S&P 500 which is down 12.21% year to date.
Becton Dickinson’s report follows an earnings beat by J&J on April 14, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B.
Pfizer had beat expectations on April 28 with first quarter EPS of $0.8 on revenue of $12.03B, compared to forecast for EPS of $0.73 on revenue of $11.81B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
